
AcouSort AB
À propos de votre organisation / profil
AcouSort provides solutions for diagnostic applications and cell therapy manufacturing enabling automated and integrated sample processing of cells and extracellular vesicles.
AcouSort’s main strategy is to develop and commercialize Original Equipment Manufacturer (OEM) components for sample preparation and processing. The OEM solutions enable integration of our technology into analytical, diagnostic, and therapeutic systems, providing automated sample preparation. The customer base for the OEM components are instrument manufacturers within the Life Science industry.
AcouSort intends to expand the portfolio of OEM components to cover a wide range of applications for clinical analysis and handling of biological samples. The Company expects the acoustic separation components to be critical components, essential for development of novel point-of-care testing devices where access to blood plasma or other fractions of blood is required. This also applies for biological sample processing systems in therapeutic settings for e.g., personalized medicine.
AcouSort’s core technology is acoustofluidics – a combination of sound waves (acousto) and microfluidics. Microfluidics allow for precise control of liquids while acoustics gives us the ability to move particles of different biophysical properties.
By combining the two technologies, we have the unique ability to move target cell types from one liquid to another. This allows us to fractionate the different components in a blood sample, isolate extracellular vesicles or wash cells to remove contaminants, without having any physical contact with the sample.
As the technology is gentle and rapid, it provides a competitive alternative to conventional processing techniques such as centrifugation or filtration. By using acoustofluidics, AcouSort can streamline sample processing for a wide range of applications – from biomarker discovery in basic research, to preparation of clinical blood samples prior to analysis, or sample purification in cell therapy manufacturing.
Réseau (0)
Il n'y a pas encore d'organisations dans le réseau.
Activités récentes

AcouSort AB a obtenu le label European Innovation Council - Transition beneficiaries.

AcouSort AB est désormais membre de la communauté EIC ACCESS+.

AcouSort AB a mis en ligne sa recherche de partenaires : Enabling automated bio-sample processing for diagnostics, cell therapy and cytometry.

Torsten Freltoft a rejoint AcouSort AB.